AIDS drugs halve HIV risk for intravenous drug users in study
By Julie Steenhuysen CHICAGO (Reuters) - A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the AIDS v...
Read More »
By Julie Steenhuysen CHICAGO (Reuters) - A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the AIDS v...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - A cap on soda size - such as the one New York City regulators are trying to pass - wo...
Read More »(Reuters) - Amgen Inc's trebananib drug for ovarian cancer extended the length of time that patients lived without the disease getti...
Read More »
By Pallavi Ail (Reuters) - Pfizer Inc said Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd would pay $2.15...
Read More »
By Ben Hirschler LONDON (Reuters) - Britain is to regulate electronic cigarettes as non-prescription medicines from 2016 in an attem...
Read More »BRUSSELS (Reuters) - Belgian biotech group Thrombogenics said on Wednesday that it received a positive initial recommendation from B...
Read More »
By Kate Kelland LONDON (Reuters) - The outlawing of drugs such as cannabis, magic mushrooms and other psychoactive substances amount...
Read More »LONDON (Reuters) - GlaxoSmithKline has finally won a green light from Britain's healthcare cost agency NICE for its platelet-boostin...
Read More »By Joseph Ax NEW YORK (Reuters) - New York City lawyers tried to convince an appeals court on Tuesday to allow Mayor Michael Bloombe...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Pregnant women who are overweight or obese are more likely to give birth prematurely,...
Read More »